Machine learning approaches for predicting the onset time of the adverse drug events in oncology

Predicting the onset time of adverse drug events can substantially lessen the negative impact on the prognosis of cancer patients who are often subject of aggressive and highly toxic treatment regimens. However, the laboratory verification of each patient case to study the mechanics of adverse drug...

Full description

Bibliographic Details
Main Authors: Mohan Timilsina, Meera Tandan, Vít Nováček
Format: Article
Language:English
Published: Elsevier 2022-09-01
Series:Machine Learning with Applications
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666827022000615
_version_ 1798004263321862144
author Mohan Timilsina
Meera Tandan
Vít Nováček
author_facet Mohan Timilsina
Meera Tandan
Vít Nováček
author_sort Mohan Timilsina
collection DOAJ
description Predicting the onset time of adverse drug events can substantially lessen the negative impact on the prognosis of cancer patients who are often subject of aggressive and highly toxic treatment regimens. However, the laboratory verification of each patient case to study the mechanics of adverse drug events requires costly, time-intensive research. Thus, to alleviate the efforts required to tackle this problem, using computational models is highly desirable. To provide a suite of such applicable models, we used openly available adverse drug event data resources called FAERS and explored various machine learning paradigms to assess their performance in predicting adverse effect onset days (since the beginning of the treatment). Among various machine learning approaches, we observed that the graph-based embedding model, particularly ComplEx, performed better than other, more traditional machine learning approaches. The embedding learned from the ComplEX trained with k-NN regression for the downstream predictive task obtained the lowest root mean square error, which we consider very promising for further research.
first_indexed 2024-04-11T12:21:54Z
format Article
id doaj.art-cc2e6e3b1fa44ef89ea49b02db6531df
institution Directory Open Access Journal
issn 2666-8270
language English
last_indexed 2024-04-11T12:21:54Z
publishDate 2022-09-01
publisher Elsevier
record_format Article
series Machine Learning with Applications
spelling doaj.art-cc2e6e3b1fa44ef89ea49b02db6531df2022-12-22T04:24:05ZengElsevierMachine Learning with Applications2666-82702022-09-019100367Machine learning approaches for predicting the onset time of the adverse drug events in oncologyMohan Timilsina0Meera Tandan1Vít Nováček2Data Science Institute, Insight Centre for Data Analytics, National University of Ireland Galway, Ireland; Corresponding author.Cecil G Sheps Center for Health Service Research, University of North Carolina, Chapel Hill, USAData Science Institute, Insight Centre for Data Analytics, National University of Ireland Galway, Ireland; Faculty of Informatics, Masaryk University Brno, Czech Republic; Masaryk Memorial Cancer Institute, Brno, Czech RepublicPredicting the onset time of adverse drug events can substantially lessen the negative impact on the prognosis of cancer patients who are often subject of aggressive and highly toxic treatment regimens. However, the laboratory verification of each patient case to study the mechanics of adverse drug events requires costly, time-intensive research. Thus, to alleviate the efforts required to tackle this problem, using computational models is highly desirable. To provide a suite of such applicable models, we used openly available adverse drug event data resources called FAERS and explored various machine learning paradigms to assess their performance in predicting adverse effect onset days (since the beginning of the treatment). Among various machine learning approaches, we observed that the graph-based embedding model, particularly ComplEx, performed better than other, more traditional machine learning approaches. The embedding learned from the ComplEX trained with k-NN regression for the downstream predictive task obtained the lowest root mean square error, which we consider very promising for further research.http://www.sciencedirect.com/science/article/pii/S2666827022000615RegressionOnsetDrugsSupervisedEmbedding
spellingShingle Mohan Timilsina
Meera Tandan
Vít Nováček
Machine learning approaches for predicting the onset time of the adverse drug events in oncology
Machine Learning with Applications
Regression
Onset
Drugs
Supervised
Embedding
title Machine learning approaches for predicting the onset time of the adverse drug events in oncology
title_full Machine learning approaches for predicting the onset time of the adverse drug events in oncology
title_fullStr Machine learning approaches for predicting the onset time of the adverse drug events in oncology
title_full_unstemmed Machine learning approaches for predicting the onset time of the adverse drug events in oncology
title_short Machine learning approaches for predicting the onset time of the adverse drug events in oncology
title_sort machine learning approaches for predicting the onset time of the adverse drug events in oncology
topic Regression
Onset
Drugs
Supervised
Embedding
url http://www.sciencedirect.com/science/article/pii/S2666827022000615
work_keys_str_mv AT mohantimilsina machinelearningapproachesforpredictingtheonsettimeoftheadversedrugeventsinoncology
AT meeratandan machinelearningapproachesforpredictingtheonsettimeoftheadversedrugeventsinoncology
AT vitnovacek machinelearningapproachesforpredictingtheonsettimeoftheadversedrugeventsinoncology